Detalhe da pesquisa
1.
Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.
J Am Acad Dermatol
; 84(2): 432-470, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32738429
2.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
J Am Acad Dermatol
; 82(1): 161-201, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703821
3.
Diagnosis and management of pemphigus: Recommendations of an international panel of experts.
J Am Acad Dermatol
; 82(3): 575-585.e1, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438767
4.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
J Am Acad Dermatol
; 82(6): 1445-1486, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32119894
5.
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
N Engl J Med
; 375(5): 422-34, 2016 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27518661
6.
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.
J Am Acad Dermatol
; 80(4): 1073-1113, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772097
7.
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
J Am Acad Dermatol
; 80(4): 1029-1072, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772098
8.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.
J Am Acad Dermatol
; 81(3): 775-804, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31351884
9.
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.
J Am Acad Dermatol
; 78(4): 741-748, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29066271
10.
Seasonal burden of National Emergency Department visits due to hidradenitis suppurativa.
J Am Acad Dermatol
; 86(6): 1362-1365, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051317
11.
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.
J Am Acad Dermatol
; 76(2): 290-298, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27908543
12.
Translating psoriasis guidelines into practice: Important gaps revealed.
J Am Acad Dermatol
; 74(3): 544-51, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26777102
13.
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
J Am Acad Dermatol
; 73(1): 37-49, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26089047
14.
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.
J Am Acad Dermatol
; 72(1): 168-74, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25443626
15.
Psoriasis disease severity affects patient satisfaction with treatment.
Dermatol Online J
; 21(7)2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26436965
16.
Research gaps in psoriasis: opportunities for future studies.
J Am Acad Dermatol
; 70(1): 146-67, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24126079
17.
Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast.
J Invest Dermatol
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431222
18.
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
Dermatol Ther (Heidelb)
; 14(2): 323-339, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340237
19.
Molecular analysis of dermatophytes suggests spread of infection among household members.
Cutis
; 91(5): 237-45, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23772429
20.
Equity in the usage of biologics for psoriasis in the working poor.
Arch Dermatol Res
; 315(4): 1029-1031, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307556